MLI experts available to comment on delay to federal drug price reduction scheme
OTTAWA, ON (June 2, 2020): Changes to the Patented Medicine Prices Review Board (PMPRB) have been delayed until January 2021 ...
Tag: Nigel Rawson
Government refuses to address real cause of missing cystic fibrosis treatment in Canada: Nigel Rawson in National Newswatch
Nothing fair exists in denying Canadian cystic fibrosis patients approved and funded access to treatments that they have been waiting ...
COVID-19, other rare disorders and the rescue principle: Nigel Rawson and John Adams for Inside Policy
Lower ceiling prices for new medicines will make Canada less attractive as a country for new drugs and vaccines, making ...
Pan-Canadian Pharmaceutical Alliance Lacks Transparency and Accountability: Nigel Rawson for Inside Policy
Negotiations to limit drug prices should not limit patients’ access to innovative drugs, writes Nigel Rawson. By Nigel Rawson, February ...
Top News
-
How post-colonialism is fuelling antisemitic protests across the West: Obaid Omer for Inside Policy
-
There’s no reason to believe CTV conspired against Pierre Poilievre. Here’s what the network actually did wrong: Peter Menzies in the Toronto Star
-
What Mark Carney should really tell the floundering federal government: Fen Osler Hampson and Tim Sargent in the Hub
-
Canada is disintegrating: Eric Kaufmann in the Telegraph
-
Canada’s NORAD modernization plan hinges on the North’s expertise and innovation: Lee Carson and Patrick Duxbury for Inside Policy
